C50.81
Malignant neoplasm of overlapping sites of breast, female
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of overlapping sites of the female breast, classified under ICD-10 code C50.81, is a type of breast cancer characterized by tumors situated across different areas of the breast tissue. Unlike localized tumors confined to a specific part of the breast, cancers with overlapping sites can involve multiple regions, making diagnosis and treatment more complex. Recognizing the patterns and understanding the characteristics of this cancer type is essential for effective management and care planning.
Causes & Symptoms
Clinical Causes: Genetic mutations that affect cell growth regulation Inherited genetic mutations, such as BRCA1 and BRCA2 Hormonal factors, like prolonged exposure to estrogen Environmental exposures to carcinogens such as radiation or certain chemicals Lifestyle factors, including obesity, alcohol consumption, and sedentary behavior History of previous breast cancer or benign breast disease
Key Symptoms: A lump or thickening in the breast tissue or underarm area Changes in the size, shape, or appearance of the breast Unexplained pain in the breast or nipple area Nipple changes, including inversion or discharge Skin changes over the breast, such as redness, dimpling, or puckering Persistent nipple or breast skin irritation
Diagnostic & Treatment
Diagnosis Path: • Additional tests like ultrasound-guided fine needle aspiration or molecular studies may be performed to evaluate tumor characteristics
Treatment Protocols: • Targeted therapy that focuses on specific molecular targets within cancer cells
Clinical Advice & FAQs
Billing Guidance
Is C50.81 a billable ICD-10 code?
Yes, C50.81 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C50.81?
Clinical documentation must specify the nature of Malignant neoplasm of overlapping sites of breast, female and any associated comorbidities for accurate reporting.
Cite this Clinical Reference